Cite
HARVARD Citation
Maio, M. et al. (2022). Health-related quality of life in patients treated with pembrolizumab for microsatellite instability–high/mismatch repair–deficient advanced solid tumours: Results from the KEYNOTE-158 study. European journal of cancer. pp. 188-197. [Online].